CLVS Options $4.605 +3.72% (0.165) unusual options activity expiring within a year

Order Side Distribution

Loading...

Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.

Top Ranked CLVS Unusual Options Activity

(latest unusual options order flow detected by AI)

Bullish Clovis Oncology, Inc. call option contracts are ones that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the upside.
The opposite applies to bearish trades: put options bought on or above the ask OR call options sold at or below the bid price - expecting a move to the downside.



Weighted Average Of Unusual Option Flow Greeks

CLVS Unusual Options Order Flow By Sentiment & Expiry


How To Trade CLVS Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Clovis Oncology, Inc.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.


Trade History